Skip to main content
. 2020 Jan 22;26(6):661–668. doi: 10.5603/CJ.a2019.0114

Figure 4.

Figure 4

Changes in fluid retention from baseline to the end of follow-up. The proportion of patients with/without decrease ( 0.5 Ω) in fluid retention from baseline to the end of 3-month follow-up in torasemide-treated patients (p = 0.51 compared to furosemide-treated patients).